Venetia Zachariou, PhD, Edward Avedisian Professor and chair of pharmacology, physiology & biophysics at Boston University Chobanian & Avedisian School of Medicine, has been named a Class of 2025 ...

Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...

Scientists uncovered how the protein Piezo1 translates physical activity into stronger bones, offering a path to ...

More than two-thirds of deaths from ovarian cancer are attributable to high-grade serous carcinoma. In one particularly aggressive form, only a small number of inactive immune cells can be found near ...

Exploring eQTL studies as a cornerstone in deciphering the genetic architecture of gene regulation Understanding the genetic ...

The study reveals a plant hormone receptor-based biosensor capable of identifying synthetic opioids, enhancing detection in ...

Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to be generally well ...

Rockville, Maryland Friday, January 9, 2026, 10:00 Hrs [IST] ...

Researchers are shifting focus from large arteries to microvessels, where nitric oxide activity may signal early circulatory ...

New Review Integrates Human, Animal, and Cellular Evidence to Reframe AD as a Triad-Centered Disorder Alzheimer’s disease (AD ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

Responsive polymers and smart materials adapt to stimuli, providing solutions to drug delivery, tissue engineering, and even ...